Cargando…

24-Hour Glycemic Variations in Drug-Naïve Patients with Type 2 Diabetes: A Continuous Glucose Monitoring (CGM)-Based Study

OBJECTIVE: To investigate a 24-hour glycemic variation in drug-naïve, type 2 diabetic patients by using CGM. METHODS: A total of 30 inpatients with type 2 diabetes were included in the study to analyze the 24-hour CGM data. RESULTS: The patients’ median age was 58 years old (interquartile range: 42–...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ando, Kiyotaka, Nishimura, Rimei, Tsujino, Daisuke, Seo, Chiaki, Utsunomiya, Kazunori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728307/ https://www.ncbi.nlm.nih.gov/pubmed/23936258 http://dx.doi.org/10.1371/journal.pone.0071102

Ejemplares similares

Comparison of vildagliptin twice daily vs. sitagliptin once daily using continuous glucose monitoring (CGM): Crossover pilot study (J-VICTORIA study)
por: Sakamoto, Masaya, et al.
Publicado: (2012)

Biphasic insulin aspart‐30 reduces glycemic variability to a greater degree than insulin detemir: A randomized controlled trial of once‐daily insulin regimens using continuous glucose monitoring
por: Tsujino, Daisuke, et al.
Publicado: (2017)

The relationship between HbA1c values and the occurrence of hypoglycemia as assessed by continuous glucose monitoring in patients with type 1 diabetes
por: Tsujino, Daisuke, et al.
Publicado: (2016)

Can Fasting Glucose Levels or Post-Breakfast Glucose Fluctuations Predict the Occurrence of Nocturnal Asymptomatic Hypoglycemia in Type 1 Diabetic Patients Receiving Basal-Bolus Insulin Therapy with Long-Acting Insulin?
por: Mitsuishi, Sumie, et al.
Publicado: (2015)

Which is better, high‐dose metformin monotherapy or low‐dose metformin/linagliptin combination therapy, in improving glycemic variability in type 2 diabetes patients with insufficient glycemic control despite low‐dose metformin monotherapy? A randomized, cross‐over, continuous glucose monitoring‐based pilot study
por: Takahashi, Hiroshi, et al.
Publicado: (2018)

Prediction of nocturnal hypoglycemia unawareness by fasting glucose levels or post-breakfast glucose fluctuations in patients with type 1 diabetes receiving insulin degludec: A pilot study
por: Takahashi, Hiroshi, et al.
Publicado: (2017)

Continuous glucose monitoring with Humalog Mix 25 versus Humalog Mix 50, twice daily: A comparative pilot study -Results from the Jikei-EValuation of insulin Lispro mixture on pharmacodynamics and glycemic VariancE (J-EVOLVE) study
por: Nishimura, Rimei, et al.
Publicado: (2010)

Effect of Hemodialysis on Plasma Glucose Profile and Plasma Level of Liraglutide in Patients with Type 2 Diabetes Mellitus and End-Stage Renal Disease: A Pilot Study
por: Osonoi, Takeshi, et al.
Publicado: (2014)

Population‐based cross‐sectional study on insulin resistance and insulin‐secretory capacity in Japanese school children
por: Nishimura, Rimei, et al.
Publicado: (2017)

Continuous glucose monitoring (CGM) in very low birth weight newborns needing parenteral nutrition: validation and glycemic percentiles.
por: Perri, Alessandro, et al.
Publicado: (2018)

SUN-146 Glucose Clearance (GLCL) Using Continuous Glucose Monitoring (CGM)
por: Melish, John
Publicado: (2019)

Efficacy of Additional Canagliflozin Administration to Type 2 Diabetes Patients Receiving Insulin Therapy: Examination of Diurnal Glycemic Patterns Using Continuous Glucose Monitoring (CGM)
por: Matsumura, Mihoko, et al.
Publicado: (2017)

Erratum to: Efficacy of Additional Canagliflozin Administration to Type 2 Diabetes Patients Receiving Insulin Therapy: Examination of Diurnal Glycemic Patterns Using Continuous Glucose Monitoring (CGM)
por: Matsumura, Mihoko, et al.
Publicado: (2017)

Comparison of Glucose Metrics Between Users of CGM Readers and CGM-Connected Apps
por: Kao, Kalvin, et al.
Publicado: (2021)

Effect of the FreeStyle Libre™ flash glucose monitoring system on glycemic control in individuals with type 2 diabetes treated with basal–bolus insulin therapy: An open label, prospective, multicenter trial in Japan
por: Ogawa, Wataru, et al.
Publicado: (2020)

Continuous Glucose Monitoring (CGM) in Sports—A Comparison between a CGM Device and Lab-Based Glucose Analyser under Resting and Exercising Conditions in Athletes
por: Bauhaus, Helen, et al.
Publicado: (2023)

Systematic review and meta-analysis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetes
por: Poolsup, Nalinee, et al.
Publicado: (2013)

24-Hour Glucose Profiles on Diets Varying in Protein Content and Glycemic Index
por: van Baak, Marleen A.
Publicado: (2014)

ODP211 Impact of Race and Chronic Kidney Disease on the Correlation between HbA1c and Continuous Glucose Monitoring (CGM) Glycemic Measures
por: Kaplan, Leah, et al.
Publicado: (2022)

OR03-3 Impact of Continuous Glucose Monitoring (CGM) on Lifestyle Modifications in Individuals with Prediabetes
por: Khan, Shanzay, et al.
Publicado: (2022)

Glycemic variability in continuous glucose monitoring is inversely associated with baroreflex sensitivity in type 2 diabetes: a preliminary report
por: Matsutani, Daisuke, et al.
Publicado: (2018)

Effect of Acetaminophen on CGM Glucose in an Outpatient Setting
por: Maahs, David M., et al.
Publicado: (2015)

Performance of the Medtronic Sentrino continuous glucose management (CGM) system in the cardiac intensive care unit
por: Kosiborod, Mikhail, et al.
Publicado: (2014)

Benefits and Drawbacks of Continuous Glucose Monitoring (CGM) Use in Young Children With Type 1 Diabetes: A Qualitative Study From a Country Where the CGM Is Not Reimbursed
por: Karakuş, Kağan Ege, et al.
Publicado: (2021)

Effect of empagliflozin monotherapy on postprandial glucose and 24-hour glucose variability in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, 4-week study
por: Nishimura, Rimei, et al.
Publicado: (2015)

Non-Alcoholic Fatty Liver Disease Markers Associated with Fasting Serum Insulin and Urinary Albumin Excretion Independent of Fasting Plasma Glucose
por: Katoh, Shuichi, et al.
Publicado: (2020)

Facilitators and Barriers to Nursing Implementation of Continuous Glucose Monitoring (CGM) in Critically Ill Patients With COVID-19
por: Faulds, Eileen R., et al.
Publicado: (2021)

Effects of reducing free sugars on 24-hour glucose profiles and glycemic variability in subjects without diabetes
por: Pappe, Christina Laeticia, et al.
Publicado: (2023)

Timing of CGM initiation in pediatric diabetes: The CGM TIME Trial
por: Lawson, Margaret L., et al.
Publicado: (2020)

MAGIC (maternal glucose in pregnancy) understanding the glycemic profile of pregnancy, intensive CGM glucose profiling and its relationship to fetal growth: an observational study protocol
por: Scott, Eleanor M, et al.
Publicado: (2023)

Accuracy of Continuous Glucose Monitoring (CGM) during Continuous and High-Intensity Interval Exercise in Patients with Type 1 Diabetes Mellitus
por: Moser, Othmar, et al.
Publicado: (2016)

Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA)
por: Moser, Othmar, et al.
Publicado: (2020)

SAT115 Diabetes In Pregnancy: Evaluating Access And Usage Of Continuous Glucose Monitors (CGM) In A Medicaid Population
por: Chilukuri, Pranaya, et al.
Publicado: (2023)

Effectiveness of Continuous Glucose Monitoring in a Clinical Care Environment: Evidence from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring (JDRF-CGM) trial
Publicado: (2010)

Prevalence of albuminuria and renal dysfunction, and related clinical factors in Japanese patients with diabetes: The Japan Diabetes Complication and its Prevention prospective study 5
por: Shikata, Kenichi, et al.
Publicado: (2019)

Evaluation of Symphony CGM, a non-invasive, transdermal continuous glucose monitoring system for use in critically ill patients
por: Joseph, J, et al.
Publicado: (2014)

Recommendations for Using Real-Time Continuous Glucose Monitoring (rtCGM) Data for Insulin Adjustments in Type 1 Diabetes
por: Pettus, Jeremy, et al.
Publicado: (2016)

Evaluation of a Fourth-Generation Subcutaneous Real-Time Continuous Glucose Monitor (CGM) in Individuals With Diabetes on Peritoneal Dialysis
por: Ng, Jack K.C., et al.
Publicado: (2023)

Heterogeneity of Responses to Real-Time Continuous Glucose Monitoring (RT-CGM) in Patients With Type 2 Diabetes and Its Implications for Application
por: Fonda, Stephanie J., et al.
Publicado: (2013)

Effects of pH, lactate, hematocrit and potassium level on the accuracy of continuous glucose monitoring (CGM) in pediatric intensive care unit
por: Marics, Gábor, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7vkcrhta2vej2fjffn2fo4r8ur